Vanguard Capital Management’s Definium Therapeutics DFTX Stock Holding History
Bought
Maintained
Sold
Other funds holding DFTX
Vanguard Capital Management's DFTX Position: Q3 2026 in Review
Vanguard Capital Management increased its Definium Therapeutics (DFTX) stake by 8.9% in Q3 2026, buying an estimated $5.56M and bringing the position to 1,618,507 shares worth $61.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1786.
Vanguard Capital Management first reported a position in DFTX in Q1 2026 and has held it in 3 quarters since. The position peaked at $69.9M in Q2 2026. 354 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.
- Vanguard Capital Management held 1,618,507 shares of Definium Therapeutics worth $61.6M as of Q3 2026.
- Vanguard Capital Management bought 132,053 Definium Therapeutics shares in Q3 2026, an estimated $5.56M.
- Definium Therapeutics made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #1786 holding.
- Vanguard Capital Management first reported a position in Definium Therapeutics in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's Definium Therapeutics position peaked at $69.9M in Q2 2026.
- 354 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.